Event JSON
{
"id": "89961eb3d3aa4850a3b66cfbdff39c34baa70634e836353e60eb0c4be0e9478e",
"pubkey": "de1abdd3127788ab39fb6f558233067d7cf07e8165598738c9a46a9cff3979a0",
"created_at": 1744585605,
"kind": 1,
"tags": [
[
"r",
"https://www.theguardian.com/society/2025/apr/14/melanoma-patients-in-england-get-fast-track-access-to-cancer-vaccine"
],
[
"subject",
"Melanoma patients in England get fast-track access to cancer vaccine"
],
[
"published_at",
"1744585227"
],
[
"image",
"https://i.guim.co.uk/img/media/40335aff708b566272e43ee09d22b8bef85fe0d6/0_160_4832_2901/master/4832.jpg?width=140\u0026quality=85\u0026auto=format\u0026fit=max\u0026s=31eedd78c09edc263a0ca1e0e46c4a41"
],
[
"p",
"de1abdd3127788ab39fb6f558233067d7cf07e8165598738c9a46a9cff3979a0",
"wss://articles.layer3.news"
],
[
"p",
"9d3345095e986ded9af724d26a8c5bee050bfd615c32fc5e76981a089c72008e",
"wss://articles.layer3.news"
],
[
"imeta",
"url https://i.guim.co.uk/img/media/40335aff708b566272e43ee09d22b8bef85fe0d6/0_160_4832_2901/master/4832.jpg?width=140\u0026quality=85\u0026auto=format\u0026fit=max\u0026s=31eedd78c09edc263a0ca1e0e46c4a41"
],
[
"t",
"Peter Johnson"
],
[
"t",
"Keir Starmer"
],
[
"t",
"Susanna Daniels"
],
[
"t",
"England"
],
[
"t",
"UK"
],
[
"t",
"health"
],
[
"t",
"liberal:perspective"
],
[
"summary",
"The NHS has launched a trial for a new cancer vaccine, known as iSCIB1+, which helps the immune system recognize cancer cells and respond to immunotherapy treatment. The vaccine is part of the Cancer Vaccine Launch Pad (CVLP) program, which aims to provide 10,000 patients in England with personalized cancer treatments by 2030. The trial is open to patients with advanced skin melanoma and will be conducted at seven hospitals across the country."
]
],
"content": "nostr:nprofile1qyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqn5e52z27npk7mxhhynfx4rzmaczshltptse0chnknqdq38rjqz8q3cttcd\nMELANOMA PATIENTS IN ENGLAND GET FAST-TRACK ACCESS TO CANCER VACCINE\n\nhttps://i.guim.co.uk/img/media/40335aff708b566272e43ee09d22b8bef85fe0d6/0_160_4832_2901/master/4832.jpg?width=140\u0026quality=85\u0026auto=format\u0026fit=max\u0026s=31eedd78c09edc263a0ca1e0e46c4a41\n--\n✍️ The NHS in England will provide fast-track access to a new cancer vaccine for patients with advanced skin melanoma as part of a trial.\n--\n👉 The NHS is launching a trial for a new cancer vaccine, iSCIB1+, for patients with advanced skin melanoma\n👉 The vaccine helps the immune system recognize cancer cells and respond to immunotherapy treatment\n👉 The trial is part of the Cancer Vaccine Launch Pad (CVLP) program, which aims to provide 10,000 patients in England with personalized cancer treatments by 2030\n👉 The trial will be conducted at seven hospitals across the country\n\n--\n#PeterJohnson #KeirStarmer #SusannaDaniels #England #UK #health\n--\nnostr:nevent1qvzqqqqqqypzp8fng5y4axrdakd0wfxjd2x9hms9p07kzhpjl308dxq6pzw8yqywqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq6yq6jm06j6mfk3aczd57gz6eur9wljslmckthye5r66w8a9tr68q5dw2um \n ",
"sig": "8b209973bfb7d8ffb7626ab9f191b1fe09b54b7f093701e49010d1bb29b96e2cc8c135c8d3a4cfaae555a25a424818b00e70441786a5778e027cccd89585d549"
}